SHIEF
Shield Therapeutics PLC

28
Loading...
Loading...
Shield Therapeutics Plc is a commercial stage specialty pharmaceutical company, which engages in addressing iron deficiency with its lead product Accrufer. It operates the Feraccru and PT20 segments. The Feraccru segment refers to the development and commercialization of this product. The PT20 segment related to the development of its secondary asset. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Gateshead Quays, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
63

Frequently Asked Questions

What is Market Cap of Shield Therapeutics plc?
What is the 52-week high for Shield Therapeutics plc?
What is the 52-week low for Shield Therapeutics plc?
What is Shield Therapeutics plc stock price today?
What was Shield Therapeutics plc stock price yesterday?
What is the PE ratio of Shield Therapeutics plc?
What is the Price-to-Book ratio of Shield Therapeutics plc?
What is the 50-day moving average of Shield Therapeutics plc?
How many employess does Shield Therapeutics plc has?

Latest SHIEF News

View
No SHIEF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.